Heather Maecker

Heather Maecker is a seasoned professional in the biotechnology and pharmaceutical sectors, currently serving as the Senior Vice President of Immuno-Oncology at Aarvik Therapeutics Inc since July 2021. Previous experience includes roles at AbbVie from 2017 to September 2021, where positions included Director II for Cell and Gene Therapy and Director of Cell Therapy and Oncolytic Viruses. Additionally, Heather held various positions at Gilead Sciences, including Senior Research Scientist II in Immunology and Inflammation, and spent six years at Genentech in roles ranging from Research Scientist in Cancer Immunology to Postdoctoral Fellow. Heather's academic background includes education at Stanford University.